| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877151 | The Annals of Thoracic Surgery | 2011 | 7 Pages |
Abstract
Allogeneic transplantation of green MSCs can be safely used to elucidate the mechanisms of cell-based therapy. The benefits of this therapy appear mainly due to the angiogenesis, not the regeneration, of cardiac myocytes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yifu MD, Suna MD, Zuxi MD, PhD, Robert F. DVM, MS, Xuan MD, Keith A. MD,